Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer

Author： Dittrich C.   Coudert B.   Paz-Ares L.   Caponigro F.   Salzberg M.   Gamucci T.   Paoletti X.   Hermans C.   Lacombe D.   Fumoleau P.   on behalf of the European Organization for Research and Treatment of Cancer-Early Clinical Studies Group/New Drug Development Programme EORTC-ECSG/NDDP  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.3, 2003-02, pp. : 330-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

By Brunsvig Paal   Aamdal Steinar   Gjertsen Marianne   Kvalheim Gunnar   Markowski-Grimsrud Carrie   Sve Ingunn   Dyrhaug Marianne   Trachsel Sissel   Møller Mona   Eriksen Jon   Gaudernack Gustav  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1553-1564

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer

By Caponigro F.   Dittrich C.   Sorensen J.B.   Schellens J.H.M.   Duffaud F.   Paz Ares L.   Lacombe D.   de Balincourt C.   Fumoleau P.  

European Journal of Cancer, Vol. 38, Iss. 1, 2002-01 ,pp. : 70-74

Elsevier

Access to resources Recommend Favorite

Phase II study of liarozole in advanced non-small cell lung cancer

By O'Byrne K.J.   Han C.   Mitchell K.   Lane D.   Carmichael J.   Harris A.L.   Talbot D.C.  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1463-1466

Elsevier

Access to resources Recommend Favorite

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer - report of a phase I/II dose-escalating study

By Thomas A.L.   Cox G.   Sharma R.A.   Steward W.P.   Shields F.   Jeyapalan K.   Muller S.   O'Byrne K.J.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2329-2334

Elsevier

Access to resources Recommend Favorite

Activity of Gemcitabine in Patients with Non-small Cell Lung Cancer: A Multicentre, Extended Phase II Study

By Gatzemeier U.   Shepherd F.A.   Le Chevalier T.   Weynants P.   Cottier B.   Groen H.J.M.   Rosso R.   Mattson K.   Cortes-Funes H.   Tonato M.   Burkes R.L.   Gottfried M.   Voi M.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 243-248

Elsevier

Access to resources Recommend Favorite